Elad Levy, MD
Neurological Surgery · Williamsville, NYNPI 1184683195
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $261,925 of the $372,561 with a category attached, or 70.3%. 32 manufacturers reported payments, led by Qapel Medical Inc at 49.5% of the total. Among neurological surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 208 payments — averaging $1791.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Qapel Medical Inc$184K
- Microvention, Inc.$62K
- Medtronic$61K
- Longeviti Neuro Solutions Inc$24K
- Stryker$13K
- Irras USA, Inc.$8K
- plus $20K from 26 others
Across 116 payments — averaging $8919.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Microvention, Inc.$627K
- Contego Medical, Inc$182K
- Medical Device Business Services, Inc.$147K
- Siemens Medical Solutions USA, Inc.$35K
- Stryker$30K
- W. L. Gore & Associates, Inc.$9K
- plus $6K from 1 others
Across 10 payments — averaging $24,715 each. An ownership or investment interest held by the physician or an immediate family member.
- Imperative Care, Inc$116K
- Borvo Medical, Inc.$105K
- Contego Medical, Inc$26K
- Longeviti Neuro Solutions Inc$0
What the payments were for
- Consulting fees$261,92570%
- Speaking & faculty fees$94,67125%
- Travel & lodging$10,1243%
- Food & beverage$5,8412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Qapel Medical Inc | 4 | $184,430 |
| Microvention, Inc. | 23 | $62,186 |
| Medtronic(2 entities) | 57 | $61,054 |
| Longeviti Neuro Solutions Inc | 7 | $24,161 |
| Stryker | 23 | $13,408 |
| Irras USA, Inc. | 2 | $7,517 |
| Penumbra, Inc. | 4 | $5,842 |
| Integra Lifesciences Corporation | 4 | $5,150 |
| Misonix Inc | 2 | $2,800 |
| Abbott | 4 | $1,451 |
| W. L. Gore & Associates, Inc. | 1 | $1,000 |
| Contego Medical, Inc | 19 | $983 |
| Globus Medical | 5 | $502 |
| Si-bone, Inc. | 6 | $405 |
| Johnson & Johnson | 14 | $308 |
| Imperative Care, Inc | 7 | $276 |
| AstraZeneca | 10 | $183 |
| Zimmer Biomet | 2 | $159 |
| Elekta, Inc. | 1 | $145 |
| Leica Microsystems Inc. | 1 | $112 |
| Baxter Healthcare | 1 | $107 |
| Prodigy Surgical Distribution, Inc. | 1 | $84 |
| Lifenet Health | 1 | $61 |
| Osteomed LLC | 1 | $58 |
| Route 92 Medical, Inc. | 1 | $38 |
| Alphatec Spine, Inc | 1 | $36 |
| Curonix LLC | 1 | $26 |
| Inspiremd Ltd | 1 | $24 |
| Boston Scientific | 1 | $21 |
| Amgen | 1 | $19 |
| Terumo Medical Corporation | 1 | $13 |
| GE HealthCare | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pipeline$30,693
- CLEARFIT$23,879
- STENT$21,866
- React$12,504
- WEB Aneurysm Embolization System$8,157
- IRRAflow$7,500
- WEB$6,000
- SURPASS$5,950
- Penumbra System$5,700
- AURORA SURGISCOPE$5,150
- FLOWGATE$5,100
- TREVO$5,100
- FRED$3,000
- BoneScalpel$2,800
- TARGET$2,550
- SYNCHRO$2,550
- SURPASS EVOLVE$2,550
- WINGSPAN$2,550
- SYNCHRO SELECT$2,550
- ONYX 18$1,875
How this compares
$372,561 in reported general payments places this provider in the 95th percentile of 446 neurological surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 16 | $12,203 |
| ClopidogrelClopidogrel Bisulfate | 101 | $497 |
| Levetiracetam | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $183 | $12,20316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 446 neurological surgery providers in New York.
Other neurological surgery in Williamsville
- Ryan DenhaeseWilliamsville$1.9M
- Adnan SiddiquiWilliamsville$1.5M
- John PollinaWilliamsville$661K
- Jeffrey MullinWilliamsville$389K
- J MoccoNew York$1.6M
- Leo HopkinsBuffalo$1.2M
- Aziz Basem QandahNew Hartford$1.1M
- Alejandro BerensteinNew York$1.1M
- Darryl LauNew York$915K
- Mark BilskyNew York$903K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.